India · Delayed Price · Currency is INR Alivus Life Sciences Statistics
Total Valuation
NSE:ALIVUS has a market cap or net worth of INR 129.55 billion. The enterprise value is 122.29 billion.
| Market Cap | 129.55B |
| Enterprise Value | 122.29B |
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | Sep 1, 2025 |
Share Statistics
NSE:ALIVUS has 122.74 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 122.74M |
| Shares Outstanding | 122.74M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 11.12% |
| Float | 30.84M |
Valuation Ratios
The trailing PE ratio is 23.00 and the forward PE ratio is 20.57. NSE:ALIVUS's PEG ratio is 2.06.
| PE Ratio | 23.00 |
| Forward PE | 20.57 |
| PS Ratio | 5.08 |
| PB Ratio | 3.89 |
| P/TBV Ratio | 3.92 |
| P/FCF Ratio | 50.14 |
| P/OCF Ratio | 22.91 |
| PEG Ratio | 2.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.34, with an EV/FCF ratio of 47.33.
| EV / Earnings | 21.66 |
| EV / Sales | 4.79 |
| EV / EBITDA | 15.34 |
| EV / EBIT | 16.94 |
| EV / FCF | 47.33 |
Financial Position
The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.21 |
| Quick Ratio | 3.72 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.22 |
| Interest Coverage | 134.39 |
Financial Efficiency
Return on equity (ROE) is 18.36% and return on invested capital (ROIC) is 21.57%.
| Return on Equity (ROE) | 18.36% |
| Return on Assets (ROA) | 12.20% |
| Return on Invested Capital (ROIC) | 21.57% |
| Return on Capital Employed (ROCE) | 20.78% |
| Weighted Average Cost of Capital (WACC) | 4.58% |
| Revenue Per Employee | 11.58M |
| Profits Per Employee | 2.56M |
| Employee Count | 2,203 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.56 |
Taxes
In the past 12 months, NSE:ALIVUS has paid 1.87 billion in taxes.
| Income Tax | 1.87B |
| Effective Tax Rate | 24.87% |
Stock Price Statistics
The stock price has increased by +0.68% in the last 52 weeks. The beta is 0.06, so NSE:ALIVUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | +0.68% |
| 50-Day Moving Average | 1,036.97 |
| 200-Day Moving Average | 949.43 |
| Relative Strength Index (RSI) | 47.48 |
| Average Volume (20 Days) | 98,921 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ALIVUS had revenue of INR 25.52 billion and earned 5.64 billion in profits. Earnings per share was 45.90.
| Revenue | 25.52B |
| Gross Profit | 14.85B |
| Operating Income | 7.22B |
| Pretax Income | 7.51B |
| Net Income | 5.64B |
| EBITDA | 7.97B |
| EBIT | 7.22B |
| Earnings Per Share (EPS) | 45.90 |
Balance Sheet
The company has 7.83 billion in cash and 567.71 million in debt, with a net cash position of 7.26 billion or 59.13 per share.
| Cash & Cash Equivalents | 7.83B |
| Total Debt | 567.71M |
| Net Cash | 7.26B |
| Net Cash Per Share | 59.13 |
| Equity (Book Value) | 33.32B |
| Book Value Per Share | 271.02 |
| Working Capital | 21.41B |
Cash Flow
In the last 12 months, operating cash flow was 5.65 billion and capital expenditures -3.07 billion, giving a free cash flow of 2.58 billion.
| Operating Cash Flow | 5.65B |
| Capital Expenditures | -3.07B |
| Depreciation & Amortization | 753.57M |
| Net Borrowing | -80.21M |
| Free Cash Flow | 2.58B |
| FCF Per Share | 21.05 |
Margins
Gross margin is 58.20%, with operating and profit margins of 28.29% and 22.12%.
| Gross Margin | 58.20% |
| Operating Margin | 28.29% |
| Pretax Margin | 29.44% |
| Profit Margin | 22.12% |
| EBITDA Margin | 31.24% |
| EBIT Margin | 28.29% |
| FCF Margin | 10.12% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.47%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.47% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 10.87% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 0.39% |
| Earnings Yield | 4.36% |
| FCF Yield | 1.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |